AWM
BIIB icon

Aevitas Wealth Management’s Biogen BIIB Stock Holding History

Aevitas Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-771
Closed -$219K – 115
2020
Q3 		$219K Hold
771
– – 0.18% 102
2020
Q2 		$206K Buy
771
+16
+2% +$4.81K 0.19% 97
2020
Q1 		$239K Hold
755
– – 0.27% 87
2019
Q4 		$224K Sell
755
-547
-42% -$152K 0.21% 104
2019
Q3 		$303K Sell
1,302
-260
-17% -$60.5K 0.3% 87
2019
Q2 		$365K Sell
1,562
-883
-36% -$204K 0.37% 77
2019
Q1 		$577K Buy
2,445
+350
+17% +$110K 0.51% 55
2018
Q4 		$630K Buy
2,095
+15
+0.7% +$4.79K 0.64% 44
2018
Q3 		$735K Buy
2,080
+50
+2% +$17.2K 0.67% 44
2018
Q2 		$589K Buy
2,030
+160
+9% +$45K 0.57% 51
2018
Q1 		$512K Sell
1,870
-200
-10% -$62.1K 0.51% 59
2017
Q4 		$659K Buy
+2,070
New +$664K 0.63% 50

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aevitas Wealth Management's BIIB Position: Q4 2020 in Review

Aevitas Wealth Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 771 shares — an estimated $219K sold.

Aevitas Wealth Management first reported a position in BIIB in Q4 2017 and held it in 12 quarters. The position peaked at $735K in Q3 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Aevitas Wealth Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Aevitas Wealth Management sold 771 Biogen shares in Q4 2020, an estimated $219K.
  • Aevitas Wealth Management first reported a position in Biogen in Q4 2017 and held it in 12 quarters.
  • Aevitas Wealth Management's Biogen position peaked at $735K in Q3 2018.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Aevitas Wealth Management's 13F filing for Q4 2020, filed 19 Jan 2021.